SCHEMBL5800338

SCHEMBL5800338

CC(C)(C)c1csc(-c2cc3cc(CCl)ccc3o2)n1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 1/20 0.37
CYP26B1 Q9NR63 1/20 0.37
F2 P00734 4/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
KMT2A Q03164 3/20 0.33
F12 P00748 1/20 0.33
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
POLB P06746 2/20 0.32
CYP19A1 P11511 1/20 0.32
GAA P10253 1/20 0.32
MEN1 O00255 2/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6598943 0.88 CYP2C8 (0.37) CYP26A1CYP26B1NPC1RAB9AKMT2A
SCHEMBL8310276 0.88 CHRM2 (0.41) CYP26A1CYP26B1NPC1RAB9AKMT2A
SCHEMBL6597050 0.87 RAB9A (0.37) CYP26A1CYP26B1NPC1RAB9APOLB
SCHEMBL6601742 0.84 ALDH1A1 (0.36) CYP26A1CYP26B1NPC1RAB9AKMT2A
SCHEMBL8316475 0.84 CYP26A1 (0.33) CYP26A1CYP26B1NPC1RAB9AKMT2A
SCHEMBL6599311 0.83 ALOX5 (0.48) CYP26A1CYP26B1NPC1RAB9AKMT2A
SCHEMBL8315448 0.82 ALOX5 (0.34) CYP26A1CYP26B1CYP19A1
SCHEMBL6600910 0.82 CYP26A1 (0.40) CYP26A1CYP26B1NPC1RAB9AKMT2A
SCHEMBL8310165 0.82 FFAR1 (0.56) CYP26A1CYP26B1NPC1RAB9AKMT2A
SCHEMBL8311016 0.82 CYP26B1 (0.42) CYP26A1CYP26B1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006046683-A1 THIAZOLYLBENZOFURAN DERIVATIVES AS LEUKOTRIENE AND PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS ASTELLAS PHARMA INC. (JP) 2006-05-04 WO disclosed
EP-1170009-B1 Thiazolybenzofuran derivatives and their use as SRS-A and leukotiene antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2004-04-07 EP disclosed
EP-1170009-A2 Thiazolybenzofuran derivatives and their use as SRS-A and leukotiene antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-01-09 EP disclosed
US-5994378-A ANTIALLERGENS; ANTIINFLAMMATORY AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-11-30 US disclosed
EP-0528337-B1 New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1999-10-20 EP disclosed
EP-0880519-A1 THIAZOLYLBENZOFURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-02 EP disclosed
WO-1997027190-A1 THIAZOLYLBENZOFURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-07-31 WO disclosed
US-5296495-A Antiallergens, antiinflammatory FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-03-22 US disclosed
EP-0528337-A1 New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-02-24 EP disclosed